Global Consumer Healthcare Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Consumer Healthcare Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Consumer health products are products sold directly to consumers. Unlike prescription drugs, selection and use of consumer health products does not require the oversight of a health care practitioner.
This report is a detailed and comprehensive analysis for global Consumer Healthcare Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Consumer Healthcare Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global Consumer Healthcare Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Consumer Healthcare Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Consumer Healthcare Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Consumer Healthcare Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Consumer Healthcare Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, AbbVie, Merck & Co., GlaxoSmithKline and Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Consumer Healthcare Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Consumer Healthcare Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Consumer Healthcare Drug, with revenue, gross margin and global market share of Consumer Healthcare Drug from 2018 to 2023.
Chapter 3, the Consumer Healthcare Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Consumer Healthcare Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Consumer Healthcare Drug.
Chapter 13, to describe Consumer Healthcare Drug research findings and conclusion.
Consumer health products are products sold directly to consumers. Unlike prescription drugs, selection and use of consumer health products does not require the oversight of a health care practitioner.
This report is a detailed and comprehensive analysis for global Consumer Healthcare Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Consumer Healthcare Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global Consumer Healthcare Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Consumer Healthcare Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Consumer Healthcare Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Consumer Healthcare Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Consumer Healthcare Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, AbbVie, Merck & Co., GlaxoSmithKline and Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Consumer Healthcare Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Solid Preparations
- Oral Liquid
- Patch
- Other
- Hospital
- Retail Pharmacy
- Other
- Johnson & Johnson
- AbbVie
- Merck & Co.
- GlaxoSmithKline
- Pfizer
- Sanofi
- Takeda
- Bayer
- Teva
- Sinopharm Group
- CR Pharmaceutical
- Shanghai Pharmaceuticals
- Hualan Bio
- North China Pharmaceutical
- Hengrui Medicine
- Fosun Pharma
- East China Medicine
- Livzon Group
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Consumer Healthcare Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Consumer Healthcare Drug, with revenue, gross margin and global market share of Consumer Healthcare Drug from 2018 to 2023.
Chapter 3, the Consumer Healthcare Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Consumer Healthcare Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Consumer Healthcare Drug.
Chapter 13, to describe Consumer Healthcare Drug research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Consumer Healthcare Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Consumer Healthcare Drug by Type
1.3.1 Overview: Global Consumer Healthcare Drug Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Consumer Healthcare Drug Consumption Value Market Share by Type in 2022
1.3.3 Solid Preparations
1.3.4 Oral Liquid
1.3.5 Patch
1.3.6 Other
1.4 Global Consumer Healthcare Drug Market by Application
1.4.1 Overview: Global Consumer Healthcare Drug Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Other
1.5 Global Consumer Healthcare Drug Market Size & Forecast
1.6 Global Consumer Healthcare Drug Market Size and Forecast by Region
1.6.1 Global Consumer Healthcare Drug Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Consumer Healthcare Drug Market Size by Region, (2018-2029)
1.6.3 North America Consumer Healthcare Drug Market Size and Prospect (2018-2029)
1.6.4 Europe Consumer Healthcare Drug Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Consumer Healthcare Drug Market Size and Prospect (2018-2029)
1.6.6 South America Consumer Healthcare Drug Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Consumer Healthcare Drug Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Consumer Healthcare Drug Product and Solutions
2.1.4 Johnson & Johnson Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Johnson & Johnson Recent Developments and Future Plans
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie Consumer Healthcare Drug Product and Solutions
2.2.4 AbbVie Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AbbVie Recent Developments and Future Plans
2.3 Merck & Co.
2.3.1 Merck & Co. Details
2.3.2 Merck & Co. Major Business
2.3.3 Merck & Co. Consumer Healthcare Drug Product and Solutions
2.3.4 Merck & Co. Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Merck & Co. Recent Developments and Future Plans
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Consumer Healthcare Drug Product and Solutions
2.4.4 GlaxoSmithKline Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GlaxoSmithKline Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Consumer Healthcare Drug Product and Solutions
2.5.4 Pfizer Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Consumer Healthcare Drug Product and Solutions
2.6.4 Sanofi Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sanofi Recent Developments and Future Plans
2.7 Takeda
2.7.1 Takeda Details
2.7.2 Takeda Major Business
2.7.3 Takeda Consumer Healthcare Drug Product and Solutions
2.7.4 Takeda Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Takeda Recent Developments and Future Plans
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business
2.8.3 Bayer Consumer Healthcare Drug Product and Solutions
2.8.4 Bayer Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bayer Recent Developments and Future Plans
2.9 Teva
2.9.1 Teva Details
2.9.2 Teva Major Business
2.9.3 Teva Consumer Healthcare Drug Product and Solutions
2.9.4 Teva Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Teva Recent Developments and Future Plans
2.10 Sinopharm Group
2.10.1 Sinopharm Group Details
2.10.2 Sinopharm Group Major Business
2.10.3 Sinopharm Group Consumer Healthcare Drug Product and Solutions
2.10.4 Sinopharm Group Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Sinopharm Group Recent Developments and Future Plans
2.11 CR Pharmaceutical
2.11.1 CR Pharmaceutical Details
2.11.2 CR Pharmaceutical Major Business
2.11.3 CR Pharmaceutical Consumer Healthcare Drug Product and Solutions
2.11.4 CR Pharmaceutical Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CR Pharmaceutical Recent Developments and Future Plans
2.12 Shanghai Pharmaceuticals
2.12.1 Shanghai Pharmaceuticals Details
2.12.2 Shanghai Pharmaceuticals Major Business
2.12.3 Shanghai Pharmaceuticals Consumer Healthcare Drug Product and Solutions
2.12.4 Shanghai Pharmaceuticals Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Shanghai Pharmaceuticals Recent Developments and Future Plans
2.13 Hualan Bio
2.13.1 Hualan Bio Details
2.13.2 Hualan Bio Major Business
2.13.3 Hualan Bio Consumer Healthcare Drug Product and Solutions
2.13.4 Hualan Bio Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Hualan Bio Recent Developments and Future Plans
2.14 North China Pharmaceutical
2.14.1 North China Pharmaceutical Details
2.14.2 North China Pharmaceutical Major Business
2.14.3 North China Pharmaceutical Consumer Healthcare Drug Product and Solutions
2.14.4 North China Pharmaceutical Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 North China Pharmaceutical Recent Developments and Future Plans
2.15 Hengrui Medicine
2.15.1 Hengrui Medicine Details
2.15.2 Hengrui Medicine Major Business
2.15.3 Hengrui Medicine Consumer Healthcare Drug Product and Solutions
2.15.4 Hengrui Medicine Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Hengrui Medicine Recent Developments and Future Plans
2.16 Fosun Pharma
2.16.1 Fosun Pharma Details
2.16.2 Fosun Pharma Major Business
2.16.3 Fosun Pharma Consumer Healthcare Drug Product and Solutions
2.16.4 Fosun Pharma Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Fosun Pharma Recent Developments and Future Plans
2.17 East China Medicine
2.17.1 East China Medicine Details
2.17.2 East China Medicine Major Business
2.17.3 East China Medicine Consumer Healthcare Drug Product and Solutions
2.17.4 East China Medicine Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 East China Medicine Recent Developments and Future Plans
2.18 Livzon Group
2.18.1 Livzon Group Details
2.18.2 Livzon Group Major Business
2.18.3 Livzon Group Consumer Healthcare Drug Product and Solutions
2.18.4 Livzon Group Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Livzon Group Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Consumer Healthcare Drug Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Consumer Healthcare Drug by Company Revenue
3.2.2 Top 3 Consumer Healthcare Drug Players Market Share in 2022
3.2.3 Top 6 Consumer Healthcare Drug Players Market Share in 2022
3.3 Consumer Healthcare Drug Market: Overall Company Footprint Analysis
3.3.1 Consumer Healthcare Drug Market: Region Footprint
3.3.2 Consumer Healthcare Drug Market: Company Product Type Footprint
3.3.3 Consumer Healthcare Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Consumer Healthcare Drug Consumption Value and Market Share by Type (2018-2023)
4.2 Global Consumer Healthcare Drug Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Consumer Healthcare Drug Consumption Value Market Share by Application (2018-2023)
5.2 Global Consumer Healthcare Drug Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Consumer Healthcare Drug Consumption Value by Type (2018-2029)
6.2 North America Consumer Healthcare Drug Consumption Value by Application (2018-2029)
6.3 North America Consumer Healthcare Drug Market Size by Country
6.3.1 North America Consumer Healthcare Drug Consumption Value by Country (2018-2029)
6.3.2 United States Consumer Healthcare Drug Market Size and Forecast (2018-2029)
6.3.3 Canada Consumer Healthcare Drug Market Size and Forecast (2018-2029)
6.3.4 Mexico Consumer Healthcare Drug Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Consumer Healthcare Drug Consumption Value by Type (2018-2029)
7.2 Europe Consumer Healthcare Drug Consumption Value by Application (2018-2029)
7.3 Europe Consumer Healthcare Drug Market Size by Country
7.3.1 Europe Consumer Healthcare Drug Consumption Value by Country (2018-2029)
7.3.2 Germany Consumer Healthcare Drug Market Size and Forecast (2018-2029)
7.3.3 France Consumer Healthcare Drug Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Consumer Healthcare Drug Market Size and Forecast (2018-2029)
7.3.5 Russia Consumer Healthcare Drug Market Size and Forecast (2018-2029)
7.3.6 Italy Consumer Healthcare Drug Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Consumer Healthcare Drug Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Consumer Healthcare Drug Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Consumer Healthcare Drug Market Size by Region
8.3.1 Asia-Pacific Consumer Healthcare Drug Consumption Value by Region (2018-2029)
8.3.2 China Consumer Healthcare Drug Market Size and Forecast (2018-2029)
8.3.3 Japan Consumer Healthcare Drug Market Size and Forecast (2018-2029)
8.3.4 South Korea Consumer Healthcare Drug Market Size and Forecast (2018-2029)
8.3.5 India Consumer Healthcare Drug Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Consumer Healthcare Drug Market Size and Forecast (2018-2029)
8.3.7 Australia Consumer Healthcare Drug Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Consumer Healthcare Drug Consumption Value by Type (2018-2029)
9.2 South America Consumer Healthcare Drug Consumption Value by Application (2018-2029)
9.3 South America Consumer Healthcare Drug Market Size by Country
9.3.1 South America Consumer Healthcare Drug Consumption Value by Country (2018-2029)
9.3.2 Brazil Consumer Healthcare Drug Market Size and Forecast (2018-2029)
9.3.3 Argentina Consumer Healthcare Drug Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Consumer Healthcare Drug Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Consumer Healthcare Drug Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Consumer Healthcare Drug Market Size by Country
10.3.1 Middle East & Africa Consumer Healthcare Drug Consumption Value by Country (2018-2029)
10.3.2 Turkey Consumer Healthcare Drug Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Consumer Healthcare Drug Market Size and Forecast (2018-2029)
10.3.4 UAE Consumer Healthcare Drug Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Consumer Healthcare Drug Market Drivers
11.2 Consumer Healthcare Drug Market Restraints
11.3 Consumer Healthcare Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Consumer Healthcare Drug Industry Chain
12.2 Consumer Healthcare Drug Upstream Analysis
12.3 Consumer Healthcare Drug Midstream Analysis
12.4 Consumer Healthcare Drug Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Consumer Healthcare Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Consumer Healthcare Drug by Type
1.3.1 Overview: Global Consumer Healthcare Drug Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Consumer Healthcare Drug Consumption Value Market Share by Type in 2022
1.3.3 Solid Preparations
1.3.4 Oral Liquid
1.3.5 Patch
1.3.6 Other
1.4 Global Consumer Healthcare Drug Market by Application
1.4.1 Overview: Global Consumer Healthcare Drug Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Other
1.5 Global Consumer Healthcare Drug Market Size & Forecast
1.6 Global Consumer Healthcare Drug Market Size and Forecast by Region
1.6.1 Global Consumer Healthcare Drug Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Consumer Healthcare Drug Market Size by Region, (2018-2029)
1.6.3 North America Consumer Healthcare Drug Market Size and Prospect (2018-2029)
1.6.4 Europe Consumer Healthcare Drug Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Consumer Healthcare Drug Market Size and Prospect (2018-2029)
1.6.6 South America Consumer Healthcare Drug Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Consumer Healthcare Drug Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Consumer Healthcare Drug Product and Solutions
2.1.4 Johnson & Johnson Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Johnson & Johnson Recent Developments and Future Plans
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie Consumer Healthcare Drug Product and Solutions
2.2.4 AbbVie Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AbbVie Recent Developments and Future Plans
2.3 Merck & Co.
2.3.1 Merck & Co. Details
2.3.2 Merck & Co. Major Business
2.3.3 Merck & Co. Consumer Healthcare Drug Product and Solutions
2.3.4 Merck & Co. Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Merck & Co. Recent Developments and Future Plans
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Consumer Healthcare Drug Product and Solutions
2.4.4 GlaxoSmithKline Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GlaxoSmithKline Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Consumer Healthcare Drug Product and Solutions
2.5.4 Pfizer Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Consumer Healthcare Drug Product and Solutions
2.6.4 Sanofi Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sanofi Recent Developments and Future Plans
2.7 Takeda
2.7.1 Takeda Details
2.7.2 Takeda Major Business
2.7.3 Takeda Consumer Healthcare Drug Product and Solutions
2.7.4 Takeda Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Takeda Recent Developments and Future Plans
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business
2.8.3 Bayer Consumer Healthcare Drug Product and Solutions
2.8.4 Bayer Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bayer Recent Developments and Future Plans
2.9 Teva
2.9.1 Teva Details
2.9.2 Teva Major Business
2.9.3 Teva Consumer Healthcare Drug Product and Solutions
2.9.4 Teva Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Teva Recent Developments and Future Plans
2.10 Sinopharm Group
2.10.1 Sinopharm Group Details
2.10.2 Sinopharm Group Major Business
2.10.3 Sinopharm Group Consumer Healthcare Drug Product and Solutions
2.10.4 Sinopharm Group Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Sinopharm Group Recent Developments and Future Plans
2.11 CR Pharmaceutical
2.11.1 CR Pharmaceutical Details
2.11.2 CR Pharmaceutical Major Business
2.11.3 CR Pharmaceutical Consumer Healthcare Drug Product and Solutions
2.11.4 CR Pharmaceutical Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CR Pharmaceutical Recent Developments and Future Plans
2.12 Shanghai Pharmaceuticals
2.12.1 Shanghai Pharmaceuticals Details
2.12.2 Shanghai Pharmaceuticals Major Business
2.12.3 Shanghai Pharmaceuticals Consumer Healthcare Drug Product and Solutions
2.12.4 Shanghai Pharmaceuticals Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Shanghai Pharmaceuticals Recent Developments and Future Plans
2.13 Hualan Bio
2.13.1 Hualan Bio Details
2.13.2 Hualan Bio Major Business
2.13.3 Hualan Bio Consumer Healthcare Drug Product and Solutions
2.13.4 Hualan Bio Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Hualan Bio Recent Developments and Future Plans
2.14 North China Pharmaceutical
2.14.1 North China Pharmaceutical Details
2.14.2 North China Pharmaceutical Major Business
2.14.3 North China Pharmaceutical Consumer Healthcare Drug Product and Solutions
2.14.4 North China Pharmaceutical Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 North China Pharmaceutical Recent Developments and Future Plans
2.15 Hengrui Medicine
2.15.1 Hengrui Medicine Details
2.15.2 Hengrui Medicine Major Business
2.15.3 Hengrui Medicine Consumer Healthcare Drug Product and Solutions
2.15.4 Hengrui Medicine Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Hengrui Medicine Recent Developments and Future Plans
2.16 Fosun Pharma
2.16.1 Fosun Pharma Details
2.16.2 Fosun Pharma Major Business
2.16.3 Fosun Pharma Consumer Healthcare Drug Product and Solutions
2.16.4 Fosun Pharma Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Fosun Pharma Recent Developments and Future Plans
2.17 East China Medicine
2.17.1 East China Medicine Details
2.17.2 East China Medicine Major Business
2.17.3 East China Medicine Consumer Healthcare Drug Product and Solutions
2.17.4 East China Medicine Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 East China Medicine Recent Developments and Future Plans
2.18 Livzon Group
2.18.1 Livzon Group Details
2.18.2 Livzon Group Major Business
2.18.3 Livzon Group Consumer Healthcare Drug Product and Solutions
2.18.4 Livzon Group Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Livzon Group Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Consumer Healthcare Drug Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Consumer Healthcare Drug by Company Revenue
3.2.2 Top 3 Consumer Healthcare Drug Players Market Share in 2022
3.2.3 Top 6 Consumer Healthcare Drug Players Market Share in 2022
3.3 Consumer Healthcare Drug Market: Overall Company Footprint Analysis
3.3.1 Consumer Healthcare Drug Market: Region Footprint
3.3.2 Consumer Healthcare Drug Market: Company Product Type Footprint
3.3.3 Consumer Healthcare Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Consumer Healthcare Drug Consumption Value and Market Share by Type (2018-2023)
4.2 Global Consumer Healthcare Drug Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Consumer Healthcare Drug Consumption Value Market Share by Application (2018-2023)
5.2 Global Consumer Healthcare Drug Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Consumer Healthcare Drug Consumption Value by Type (2018-2029)
6.2 North America Consumer Healthcare Drug Consumption Value by Application (2018-2029)
6.3 North America Consumer Healthcare Drug Market Size by Country
6.3.1 North America Consumer Healthcare Drug Consumption Value by Country (2018-2029)
6.3.2 United States Consumer Healthcare Drug Market Size and Forecast (2018-2029)
6.3.3 Canada Consumer Healthcare Drug Market Size and Forecast (2018-2029)
6.3.4 Mexico Consumer Healthcare Drug Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Consumer Healthcare Drug Consumption Value by Type (2018-2029)
7.2 Europe Consumer Healthcare Drug Consumption Value by Application (2018-2029)
7.3 Europe Consumer Healthcare Drug Market Size by Country
7.3.1 Europe Consumer Healthcare Drug Consumption Value by Country (2018-2029)
7.3.2 Germany Consumer Healthcare Drug Market Size and Forecast (2018-2029)
7.3.3 France Consumer Healthcare Drug Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Consumer Healthcare Drug Market Size and Forecast (2018-2029)
7.3.5 Russia Consumer Healthcare Drug Market Size and Forecast (2018-2029)
7.3.6 Italy Consumer Healthcare Drug Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Consumer Healthcare Drug Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Consumer Healthcare Drug Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Consumer Healthcare Drug Market Size by Region
8.3.1 Asia-Pacific Consumer Healthcare Drug Consumption Value by Region (2018-2029)
8.3.2 China Consumer Healthcare Drug Market Size and Forecast (2018-2029)
8.3.3 Japan Consumer Healthcare Drug Market Size and Forecast (2018-2029)
8.3.4 South Korea Consumer Healthcare Drug Market Size and Forecast (2018-2029)
8.3.5 India Consumer Healthcare Drug Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Consumer Healthcare Drug Market Size and Forecast (2018-2029)
8.3.7 Australia Consumer Healthcare Drug Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Consumer Healthcare Drug Consumption Value by Type (2018-2029)
9.2 South America Consumer Healthcare Drug Consumption Value by Application (2018-2029)
9.3 South America Consumer Healthcare Drug Market Size by Country
9.3.1 South America Consumer Healthcare Drug Consumption Value by Country (2018-2029)
9.3.2 Brazil Consumer Healthcare Drug Market Size and Forecast (2018-2029)
9.3.3 Argentina Consumer Healthcare Drug Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Consumer Healthcare Drug Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Consumer Healthcare Drug Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Consumer Healthcare Drug Market Size by Country
10.3.1 Middle East & Africa Consumer Healthcare Drug Consumption Value by Country (2018-2029)
10.3.2 Turkey Consumer Healthcare Drug Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Consumer Healthcare Drug Market Size and Forecast (2018-2029)
10.3.4 UAE Consumer Healthcare Drug Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Consumer Healthcare Drug Market Drivers
11.2 Consumer Healthcare Drug Market Restraints
11.3 Consumer Healthcare Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Consumer Healthcare Drug Industry Chain
12.2 Consumer Healthcare Drug Upstream Analysis
12.3 Consumer Healthcare Drug Midstream Analysis
12.4 Consumer Healthcare Drug Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Consumer Healthcare Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Consumer Healthcare Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Consumer Healthcare Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Consumer Healthcare Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 6. Johnson & Johnson Major Business
Table 7. Johnson & Johnson Consumer Healthcare Drug Product and Solutions
Table 8. Johnson & Johnson Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Johnson & Johnson Recent Developments and Future Plans
Table 10. AbbVie Company Information, Head Office, and Major Competitors
Table 11. AbbVie Major Business
Table 12. AbbVie Consumer Healthcare Drug Product and Solutions
Table 13. AbbVie Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. AbbVie Recent Developments and Future Plans
Table 15. Merck & Co. Company Information, Head Office, and Major Competitors
Table 16. Merck & Co. Major Business
Table 17. Merck & Co. Consumer Healthcare Drug Product and Solutions
Table 18. Merck & Co. Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Merck & Co. Recent Developments and Future Plans
Table 20. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 21. GlaxoSmithKline Major Business
Table 22. GlaxoSmithKline Consumer Healthcare Drug Product and Solutions
Table 23. GlaxoSmithKline Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. GlaxoSmithKline Recent Developments and Future Plans
Table 25. Pfizer Company Information, Head Office, and Major Competitors
Table 26. Pfizer Major Business
Table 27. Pfizer Consumer Healthcare Drug Product and Solutions
Table 28. Pfizer Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Pfizer Recent Developments and Future Plans
Table 30. Sanofi Company Information, Head Office, and Major Competitors
Table 31. Sanofi Major Business
Table 32. Sanofi Consumer Healthcare Drug Product and Solutions
Table 33. Sanofi Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Sanofi Recent Developments and Future Plans
Table 35. Takeda Company Information, Head Office, and Major Competitors
Table 36. Takeda Major Business
Table 37. Takeda Consumer Healthcare Drug Product and Solutions
Table 38. Takeda Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Takeda Recent Developments and Future Plans
Table 40. Bayer Company Information, Head Office, and Major Competitors
Table 41. Bayer Major Business
Table 42. Bayer Consumer Healthcare Drug Product and Solutions
Table 43. Bayer Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Bayer Recent Developments and Future Plans
Table 45. Teva Company Information, Head Office, and Major Competitors
Table 46. Teva Major Business
Table 47. Teva Consumer Healthcare Drug Product and Solutions
Table 48. Teva Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Teva Recent Developments and Future Plans
Table 50. Sinopharm Group Company Information, Head Office, and Major Competitors
Table 51. Sinopharm Group Major Business
Table 52. Sinopharm Group Consumer Healthcare Drug Product and Solutions
Table 53. Sinopharm Group Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Sinopharm Group Recent Developments and Future Plans
Table 55. CR Pharmaceutical Company Information, Head Office, and Major Competitors
Table 56. CR Pharmaceutical Major Business
Table 57. CR Pharmaceutical Consumer Healthcare Drug Product and Solutions
Table 58. CR Pharmaceutical Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. CR Pharmaceutical Recent Developments and Future Plans
Table 60. Shanghai Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 61. Shanghai Pharmaceuticals Major Business
Table 62. Shanghai Pharmaceuticals Consumer Healthcare Drug Product and Solutions
Table 63. Shanghai Pharmaceuticals Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Shanghai Pharmaceuticals Recent Developments and Future Plans
Table 65. Hualan Bio Company Information, Head Office, and Major Competitors
Table 66. Hualan Bio Major Business
Table 67. Hualan Bio Consumer Healthcare Drug Product and Solutions
Table 68. Hualan Bio Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Hualan Bio Recent Developments and Future Plans
Table 70. North China Pharmaceutical Company Information, Head Office, and Major Competitors
Table 71. North China Pharmaceutical Major Business
Table 72. North China Pharmaceutical Consumer Healthcare Drug Product and Solutions
Table 73. North China Pharmaceutical Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. North China Pharmaceutical Recent Developments and Future Plans
Table 75. Hengrui Medicine Company Information, Head Office, and Major Competitors
Table 76. Hengrui Medicine Major Business
Table 77. Hengrui Medicine Consumer Healthcare Drug Product and Solutions
Table 78. Hengrui Medicine Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Hengrui Medicine Recent Developments and Future Plans
Table 80. Fosun Pharma Company Information, Head Office, and Major Competitors
Table 81. Fosun Pharma Major Business
Table 82. Fosun Pharma Consumer Healthcare Drug Product and Solutions
Table 83. Fosun Pharma Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Fosun Pharma Recent Developments and Future Plans
Table 85. East China Medicine Company Information, Head Office, and Major Competitors
Table 86. East China Medicine Major Business
Table 87. East China Medicine Consumer Healthcare Drug Product and Solutions
Table 88. East China Medicine Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. East China Medicine Recent Developments and Future Plans
Table 90. Livzon Group Company Information, Head Office, and Major Competitors
Table 91. Livzon Group Major Business
Table 92. Livzon Group Consumer Healthcare Drug Product and Solutions
Table 93. Livzon Group Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Livzon Group Recent Developments and Future Plans
Table 95. Global Consumer Healthcare Drug Revenue (USD Million) by Players (2018-2023)
Table 96. Global Consumer Healthcare Drug Revenue Share by Players (2018-2023)
Table 97. Breakdown of Consumer Healthcare Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Consumer Healthcare Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 99. Head Office of Key Consumer Healthcare Drug Players
Table 100. Consumer Healthcare Drug Market: Company Product Type Footprint
Table 101. Consumer Healthcare Drug Market: Company Product Application Footprint
Table 102. Consumer Healthcare Drug New Market Entrants and Barriers to Market Entry
Table 103. Consumer Healthcare Drug Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Consumer Healthcare Drug Consumption Value (USD Million) by Type (2018-2023)
Table 105. Global Consumer Healthcare Drug Consumption Value Share by Type (2018-2023)
Table 106. Global Consumer Healthcare Drug Consumption Value Forecast by Type (2024-2029)
Table 107. Global Consumer Healthcare Drug Consumption Value by Application (2018-2023)
Table 108. Global Consumer Healthcare Drug Consumption Value Forecast by Application (2024-2029)
Table 109. North America Consumer Healthcare Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 110. North America Consumer Healthcare Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 111. North America Consumer Healthcare Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 112. North America Consumer Healthcare Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 113. North America Consumer Healthcare Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 114. North America Consumer Healthcare Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 115. Europe Consumer Healthcare Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Europe Consumer Healthcare Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Europe Consumer Healthcare Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 118. Europe Consumer Healthcare Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 119. Europe Consumer Healthcare Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Consumer Healthcare Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Consumer Healthcare Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 122. Asia-Pacific Consumer Healthcare Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 123. Asia-Pacific Consumer Healthcare Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 124. Asia-Pacific Consumer Healthcare Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 125. Asia-Pacific Consumer Healthcare Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 126. Asia-Pacific Consumer Healthcare Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 127. South America Consumer Healthcare Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 128. South America Consumer Healthcare Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 129. South America Consumer Healthcare Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 130. South America Consumer Healthcare Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 131. South America Consumer Healthcare Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 132. South America Consumer Healthcare Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Middle East & Africa Consumer Healthcare Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 134. Middle East & Africa Consumer Healthcare Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 135. Middle East & Africa Consumer Healthcare Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 136. Middle East & Africa Consumer Healthcare Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 137. Middle East & Africa Consumer Healthcare Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 138. Middle East & Africa Consumer Healthcare Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 139. Consumer Healthcare Drug Raw Material
Table 140. Key Suppliers of Consumer Healthcare Drug Raw Materials
Table 1. Global Consumer Healthcare Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Consumer Healthcare Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Consumer Healthcare Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Consumer Healthcare Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 6. Johnson & Johnson Major Business
Table 7. Johnson & Johnson Consumer Healthcare Drug Product and Solutions
Table 8. Johnson & Johnson Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Johnson & Johnson Recent Developments and Future Plans
Table 10. AbbVie Company Information, Head Office, and Major Competitors
Table 11. AbbVie Major Business
Table 12. AbbVie Consumer Healthcare Drug Product and Solutions
Table 13. AbbVie Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. AbbVie Recent Developments and Future Plans
Table 15. Merck & Co. Company Information, Head Office, and Major Competitors
Table 16. Merck & Co. Major Business
Table 17. Merck & Co. Consumer Healthcare Drug Product and Solutions
Table 18. Merck & Co. Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Merck & Co. Recent Developments and Future Plans
Table 20. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 21. GlaxoSmithKline Major Business
Table 22. GlaxoSmithKline Consumer Healthcare Drug Product and Solutions
Table 23. GlaxoSmithKline Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. GlaxoSmithKline Recent Developments and Future Plans
Table 25. Pfizer Company Information, Head Office, and Major Competitors
Table 26. Pfizer Major Business
Table 27. Pfizer Consumer Healthcare Drug Product and Solutions
Table 28. Pfizer Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Pfizer Recent Developments and Future Plans
Table 30. Sanofi Company Information, Head Office, and Major Competitors
Table 31. Sanofi Major Business
Table 32. Sanofi Consumer Healthcare Drug Product and Solutions
Table 33. Sanofi Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Sanofi Recent Developments and Future Plans
Table 35. Takeda Company Information, Head Office, and Major Competitors
Table 36. Takeda Major Business
Table 37. Takeda Consumer Healthcare Drug Product and Solutions
Table 38. Takeda Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Takeda Recent Developments and Future Plans
Table 40. Bayer Company Information, Head Office, and Major Competitors
Table 41. Bayer Major Business
Table 42. Bayer Consumer Healthcare Drug Product and Solutions
Table 43. Bayer Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Bayer Recent Developments and Future Plans
Table 45. Teva Company Information, Head Office, and Major Competitors
Table 46. Teva Major Business
Table 47. Teva Consumer Healthcare Drug Product and Solutions
Table 48. Teva Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Teva Recent Developments and Future Plans
Table 50. Sinopharm Group Company Information, Head Office, and Major Competitors
Table 51. Sinopharm Group Major Business
Table 52. Sinopharm Group Consumer Healthcare Drug Product and Solutions
Table 53. Sinopharm Group Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Sinopharm Group Recent Developments and Future Plans
Table 55. CR Pharmaceutical Company Information, Head Office, and Major Competitors
Table 56. CR Pharmaceutical Major Business
Table 57. CR Pharmaceutical Consumer Healthcare Drug Product and Solutions
Table 58. CR Pharmaceutical Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. CR Pharmaceutical Recent Developments and Future Plans
Table 60. Shanghai Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 61. Shanghai Pharmaceuticals Major Business
Table 62. Shanghai Pharmaceuticals Consumer Healthcare Drug Product and Solutions
Table 63. Shanghai Pharmaceuticals Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Shanghai Pharmaceuticals Recent Developments and Future Plans
Table 65. Hualan Bio Company Information, Head Office, and Major Competitors
Table 66. Hualan Bio Major Business
Table 67. Hualan Bio Consumer Healthcare Drug Product and Solutions
Table 68. Hualan Bio Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Hualan Bio Recent Developments and Future Plans
Table 70. North China Pharmaceutical Company Information, Head Office, and Major Competitors
Table 71. North China Pharmaceutical Major Business
Table 72. North China Pharmaceutical Consumer Healthcare Drug Product and Solutions
Table 73. North China Pharmaceutical Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. North China Pharmaceutical Recent Developments and Future Plans
Table 75. Hengrui Medicine Company Information, Head Office, and Major Competitors
Table 76. Hengrui Medicine Major Business
Table 77. Hengrui Medicine Consumer Healthcare Drug Product and Solutions
Table 78. Hengrui Medicine Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Hengrui Medicine Recent Developments and Future Plans
Table 80. Fosun Pharma Company Information, Head Office, and Major Competitors
Table 81. Fosun Pharma Major Business
Table 82. Fosun Pharma Consumer Healthcare Drug Product and Solutions
Table 83. Fosun Pharma Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Fosun Pharma Recent Developments and Future Plans
Table 85. East China Medicine Company Information, Head Office, and Major Competitors
Table 86. East China Medicine Major Business
Table 87. East China Medicine Consumer Healthcare Drug Product and Solutions
Table 88. East China Medicine Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. East China Medicine Recent Developments and Future Plans
Table 90. Livzon Group Company Information, Head Office, and Major Competitors
Table 91. Livzon Group Major Business
Table 92. Livzon Group Consumer Healthcare Drug Product and Solutions
Table 93. Livzon Group Consumer Healthcare Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Livzon Group Recent Developments and Future Plans
Table 95. Global Consumer Healthcare Drug Revenue (USD Million) by Players (2018-2023)
Table 96. Global Consumer Healthcare Drug Revenue Share by Players (2018-2023)
Table 97. Breakdown of Consumer Healthcare Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Consumer Healthcare Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 99. Head Office of Key Consumer Healthcare Drug Players
Table 100. Consumer Healthcare Drug Market: Company Product Type Footprint
Table 101. Consumer Healthcare Drug Market: Company Product Application Footprint
Table 102. Consumer Healthcare Drug New Market Entrants and Barriers to Market Entry
Table 103. Consumer Healthcare Drug Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Consumer Healthcare Drug Consumption Value (USD Million) by Type (2018-2023)
Table 105. Global Consumer Healthcare Drug Consumption Value Share by Type (2018-2023)
Table 106. Global Consumer Healthcare Drug Consumption Value Forecast by Type (2024-2029)
Table 107. Global Consumer Healthcare Drug Consumption Value by Application (2018-2023)
Table 108. Global Consumer Healthcare Drug Consumption Value Forecast by Application (2024-2029)
Table 109. North America Consumer Healthcare Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 110. North America Consumer Healthcare Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 111. North America Consumer Healthcare Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 112. North America Consumer Healthcare Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 113. North America Consumer Healthcare Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 114. North America Consumer Healthcare Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 115. Europe Consumer Healthcare Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Europe Consumer Healthcare Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Europe Consumer Healthcare Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 118. Europe Consumer Healthcare Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 119. Europe Consumer Healthcare Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Consumer Healthcare Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Consumer Healthcare Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 122. Asia-Pacific Consumer Healthcare Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 123. Asia-Pacific Consumer Healthcare Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 124. Asia-Pacific Consumer Healthcare Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 125. Asia-Pacific Consumer Healthcare Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 126. Asia-Pacific Consumer Healthcare Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 127. South America Consumer Healthcare Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 128. South America Consumer Healthcare Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 129. South America Consumer Healthcare Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 130. South America Consumer Healthcare Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 131. South America Consumer Healthcare Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 132. South America Consumer Healthcare Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Middle East & Africa Consumer Healthcare Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 134. Middle East & Africa Consumer Healthcare Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 135. Middle East & Africa Consumer Healthcare Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 136. Middle East & Africa Consumer Healthcare Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 137. Middle East & Africa Consumer Healthcare Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 138. Middle East & Africa Consumer Healthcare Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 139. Consumer Healthcare Drug Raw Material
Table 140. Key Suppliers of Consumer Healthcare Drug Raw Materials
LIST OF FIGURES
Figure 1. Consumer Healthcare Drug Picture
Figure 2. Global Consumer Healthcare Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Consumer Healthcare Drug Consumption Value Market Share by Type in 2022
Figure 4. Solid Preparations
Figure 5. Oral Liquid
Figure 6. Patch
Figure 7. Other
Figure 8. Global Consumer Healthcare Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Consumer Healthcare Drug Consumption Value Market Share by Application in 2022
Figure 10. Hospital Picture
Figure 11. Retail Pharmacy Picture
Figure 12. Other Picture
Figure 13. Global Consumer Healthcare Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Consumer Healthcare Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Consumer Healthcare Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Consumer Healthcare Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Consumer Healthcare Drug Consumption Value Market Share by Region in 2022
Figure 18. North America Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Consumer Healthcare Drug Revenue Share by Players in 2022
Figure 24. Consumer Healthcare Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Consumer Healthcare Drug Market Share in 2022
Figure 26. Global Top 6 Players Consumer Healthcare Drug Market Share in 2022
Figure 27. Global Consumer Healthcare Drug Consumption Value Share by Type (2018-2023)
Figure 28. Global Consumer Healthcare Drug Market Share Forecast by Type (2024-2029)
Figure 29. Global Consumer Healthcare Drug Consumption Value Share by Application (2018-2023)
Figure 30. Global Consumer Healthcare Drug Market Share Forecast by Application (2024-2029)
Figure 31. North America Consumer Healthcare Drug Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Consumer Healthcare Drug Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Consumer Healthcare Drug Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Consumer Healthcare Drug Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Consumer Healthcare Drug Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Consumer Healthcare Drug Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 41. France Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Consumer Healthcare Drug Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Consumer Healthcare Drug Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Consumer Healthcare Drug Consumption Value Market Share by Region (2018-2029)
Figure 48. China Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 51. India Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Consumer Healthcare Drug Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Consumer Healthcare Drug Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Consumer Healthcare Drug Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Consumer Healthcare Drug Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Consumer Healthcare Drug Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Consumer Healthcare Drug Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 65. Consumer Healthcare Drug Market Drivers
Figure 66. Consumer Healthcare Drug Market Restraints
Figure 67. Consumer Healthcare Drug Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Consumer Healthcare Drug in 2022
Figure 70. Manufacturing Process Analysis of Consumer Healthcare Drug
Figure 71. Consumer Healthcare Drug Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Consumer Healthcare Drug Picture
Figure 2. Global Consumer Healthcare Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Consumer Healthcare Drug Consumption Value Market Share by Type in 2022
Figure 4. Solid Preparations
Figure 5. Oral Liquid
Figure 6. Patch
Figure 7. Other
Figure 8. Global Consumer Healthcare Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Consumer Healthcare Drug Consumption Value Market Share by Application in 2022
Figure 10. Hospital Picture
Figure 11. Retail Pharmacy Picture
Figure 12. Other Picture
Figure 13. Global Consumer Healthcare Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Consumer Healthcare Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Consumer Healthcare Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Consumer Healthcare Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Consumer Healthcare Drug Consumption Value Market Share by Region in 2022
Figure 18. North America Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Consumer Healthcare Drug Revenue Share by Players in 2022
Figure 24. Consumer Healthcare Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Consumer Healthcare Drug Market Share in 2022
Figure 26. Global Top 6 Players Consumer Healthcare Drug Market Share in 2022
Figure 27. Global Consumer Healthcare Drug Consumption Value Share by Type (2018-2023)
Figure 28. Global Consumer Healthcare Drug Market Share Forecast by Type (2024-2029)
Figure 29. Global Consumer Healthcare Drug Consumption Value Share by Application (2018-2023)
Figure 30. Global Consumer Healthcare Drug Market Share Forecast by Application (2024-2029)
Figure 31. North America Consumer Healthcare Drug Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Consumer Healthcare Drug Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Consumer Healthcare Drug Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Consumer Healthcare Drug Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Consumer Healthcare Drug Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Consumer Healthcare Drug Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 41. France Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Consumer Healthcare Drug Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Consumer Healthcare Drug Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Consumer Healthcare Drug Consumption Value Market Share by Region (2018-2029)
Figure 48. China Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 51. India Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Consumer Healthcare Drug Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Consumer Healthcare Drug Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Consumer Healthcare Drug Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Consumer Healthcare Drug Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Consumer Healthcare Drug Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Consumer Healthcare Drug Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Consumer Healthcare Drug Consumption Value (2018-2029) & (USD Million)
Figure 65. Consumer Healthcare Drug Market Drivers
Figure 66. Consumer Healthcare Drug Market Restraints
Figure 67. Consumer Healthcare Drug Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Consumer Healthcare Drug in 2022
Figure 70. Manufacturing Process Analysis of Consumer Healthcare Drug
Figure 71. Consumer Healthcare Drug Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
